twenty-six patients ( 25 evaluable for response ) with previously treated metastatic breast cancer were treated with intermediate-dose methotrexate ( 300 mg/m2 ) followed by 5-fluorouracil ( 600 mg/m2 ) and folinic acid-sf ( leucovorin ) rescue ( 10 mg/m2 q 6 h x 6 doses ) with or without tamoxifen ( 20 mg ) and conjugated estrogen ( premarin ) ( .625 mg twice daily ) depending on receptor status .
C0014938
conjugated estrogen
C0699710
premarin